ASHLEY KEEL: Open Payments
NPI 1588336580 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 18 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $359 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| AERIN MEDICAL INC. | 2 | $189 |
| Regeneron Healthcare Solutions, Inc. | 7 | $155 |
| GENZYME CORPORATION | 2 | $55 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| ALK-Abello, Inc | 2 | $32 |
| Optinose US, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: DUPIXENT, VIVAER STYLUS, Ryaltris, Ragwitek, Xhance, VOQUEZNA, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
